https://www.cidrap.umn.edu/news-perspective/2022/11/study-ties-paxlovid-lower-covid-19-hospitalization-rate
Adult US COVID-19 patients who received the antiviral drug Paxlovid within 5 days after diagnosis had a 51% lower hospitalization rate than nonrecipients, according to an observational study yesterday in Morbidity and Mortality Weekly Report.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.